Newsroom

August 5, 2021
ESG commitments help illustrate company’s culture and benchmark future goals PORTLAND, Maine --(BUSINESS WIRE)--Aug. 5, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today released its first Environmental, Social and Governance report since forming just
August 5, 2021
Second quarter GAAP net sales of $1.19 billion , an increase of 16% year-over-year; non-GAAP organic net sales increased 12% year-over-year Second quarter GAAP net loss attributable to Covetrus of $31 million versus GAAP net income of $54 million in the prior year period; second quarter non-GAAP
July 22, 2021
Drew Coxhead brings deep accounting experience to support Covetrus’ transformation PORTLAND, Maine --(BUSINESS WIRE)--Jul. 22, 2021-- Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that Drew Coxhead will be appointed as vice president, corporate
June 30, 2021
Animal health leader to combine practice, prescription, and wellness management for better veterinarian-client relationships, practice revenue and healthcare outcomes. PORTLAND, Maine & IRVINE, Calif. --(BUSINESS WIRE)--Jun. 30, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health
June 6, 2021
Digital scripts drive health, growth and wellness for busy veterinary clinics PORTLAND, Maine --(BUSINESS WIRE)--Jun. 6, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced an enhancement to their leading practice management software to help today’s
May 18, 2021
Fonteyne, former CEO of Boehringer-Ingelheim USA , brings 30+ years of pharmaceutical and animal healthcare experience to the Covetrus board PORTLAND, Maine --(BUSINESS WIRE)--May 18, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced the
May 6, 2021
First quarter GAAP net sales of $1.10 billion , an increase of 3% year-over-year; non-GAAP organic net sales increased 4% year-over-year First quarter GAAP net loss of $16 million versus a net loss of $33 million in the prior year period; first quarter non-GAAP adjusted net income of $29 million ,